Arrythmia Cardiovascular hospitalization and length of stay declined significantly in patients with paroxysmal or persistent atrial fibrillation or flutter treated with dronedarone (Multaq), a post hoc analysis of a large randomized trial showed. First cardiovascular hospitalization occurred in 26% fewer patients treated with dronedarone versus placebo, and the rate of hospitalization for Afib was almost […]